Clinical Trial Update: Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing intranasal insulin to enhance cerebral vasoreactivity and cognition in adults with type 2 diabetes; trial completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Intranasal insulin (insulin)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2014-10-28